Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2
- 1 November 1989
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 38 (21) , 3645-3651
- https://doi.org/10.1016/0006-2952(89)90567-4
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Lipocortin and the mechanism of action of the glucocorticoidsBritish Journal of Pharmacology, 1988
- Regulation of Eicosanoid Production: Role of Phospholipases and InhibitorsNature Biotechnology, 1987
- Primary sequence of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortinBiochemistry, 1986
- The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeatsCell, 1986
- Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinaseCell, 1986
- Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activityNature, 1986
- Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteinsEuropean Journal of Pharmacology, 1984
- Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulinBiochemical and Biophysical Research Communications, 1982
- GLUCOCORTICOIDS INDUCE THE FORMATION AND RELEASE OF ANTI‐INFLAMMATORY AND ANTI‐PHOSPHOLIPASE PROTEINS INTO THE PERITONEAL CAVITY OF THE RATBritish Journal of Pharmacology, 1982
- Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesisNature, 1978